Suvorexant Patent Expiration
Suvorexant is Used for promoting sleep and treating insomnia. It was first introduced by Merck Sharp And Dohme Corp
Suvorexant Patents
Given below is the list of patents protecting Suvorexant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Belsomra | US10098892 | Solid dosage formulations of an orexin receptor antagonist | May 29, 2033 | Merck Sharp Dohme |
| Belsomra | US11980623 | Solid dosage formulations of an orexin receptor antagonist | May 29, 2033 | Merck Sharp Dohme |
| Belsomra | US7951797 | Substituted diazepan orexin receptor antagonists | Nov 20, 2029 | Merck Sharp Dohme |
Suvorexant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List